Chapters

Transcript

Video

Can you review the mechanism of action of IL-6 inhibitors in RA, and what we have learned from trials evaluating the safety and efficacy of sarilumab, tocilizumab, and other drugs in this class?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Roy Fleischmann, MD

Roy Fleischmann, MD

Clinical Professor of Medicine
University of Texas Southwestern Medical Center at Dallas
Co-Director, Division of Rheumatology
Texas Health Presbyterian Medical Center and Co-Medical Director
Metroplex Clinical Research Center